Prevalence of Subclinical Thyroid Dysfunction and Its Relation to Socioeconomic Deprivation in the Elderly: A Community-Based Cross-Sectional Survey
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
CONTEXT: Population-based screening has been advocated for subclinical thyroid dysfunction in the elderly because the disorder is perceived to be common, and health benefits may be accrued by detection and treatment. OBJECTIVE: The objective of the study was to determine the prevalence of subclinical thyroid dysfunction and unidentified overt thyroid dysfunction in an elderly population. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional survey of a community sample of participants aged 65 yr and older registered with 20 family practices in the United Kingdom. EXCLUSIONS: Exclusions included current therapy for thyroid disease, thyroid surgery, or treatment within 12 months. OUTCOME MEASURE: Tests of thyroid function (TSH concentration and free T4 concentration in all, with measurement of free T3 in those with low TSH) were conducted. EXPLANATORY VARIABLES: These included all current medical diagnoses and drug therapies, age, gender, and socioeconomic deprivation (Index of Multiple Deprivation, 2004). ANALYSIS: Standardized prevalence rates were analyzed. Logistic regression modeling was used to determine factors associated with the presence of subclinical thyroid dysfunction. RESULTS: A total of 5960 attended for screening. Using biochemical definitions, 94.2% [95% confidence interval (CI) 93.8-94.6%] were euthyroid. Unidentified overt hyper- and hypothyroidism were uncommon (0.3, 0.4%, respectively). Subclinical hyperthyroidism and hypothyroidism were identified with similar frequency (2.1%, 95% CI 1.8-2.3%; 2.9%, 95% CI 2.6-3.1%, respectively). Subclinical thyroid dysfunction was more common in females (P < 0.001) and with increasing age (P < 0.001). After allowing for comorbidities, concurrent drug therapies, age, and gender, an association between subclinical hyperthyroidism and a composite measure of socioeconomic deprivation remained. CONCLUSIONS: Undiagnosed overt thyroid dysfunction is uncommon. The prevalence of subclinical thyroid dysfunction is 5%. We have, for the first time, identified an independent association between the prevalence of subclinical thyroid dysfunction and deprivation that cannot be explained solely by the greater burden of chronic disease and/or consequent drug therapies in the deprived population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · cited 2×
“other studies (9, 25, 42, 43), although they are considerably”
BackgroundThe Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Thyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899 · cited 1×
“of subclinical hypothyroidism are much less well established, and although an elevated TSH in the elderly has been recently suggested as conferring a mortality advantage, (4), most of the literature refers to adverse consequences such as the possibility of cardiac dysfunction or adverse cardiac end points (including a…”
BackgroundThyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Baskin, H. J., Cobin, R. H., Duick, D. S., Gharib, H., Guttler, R. B., Kaplan, M. M., Segal, R. L., Garber, J. R., Hamilton Jr, C. R., Handelsman, Y., et al. (2002) · Endocrine Practice · doi:10.4158/1934-2403-8.6.457 · Cited by 673
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669 · cited 1×
“Subclinical hyperthyroidism may also be associated with adverse cardiac end points (10, 11) including atrial fibrillation (12), cardiac dysfunction, systemic and circulatory disease mortality (13), neuropsychiatric symptoms (14, 15), reduced bone mineral density, and fractures (16, 17).”
BackgroundSelf-citationFade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567 · cited 3×
“4%) of known overt thyroid dysfunction thanthedatareportedhere(19).”
BackgroundResultSelf-citationSubclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536 · cited 1×
“Subclinical hyperthyroidism may also be associated with adverse cardiac end points (10, 11) including atrial fibrillation (12), cardiac dysfunction, systemic and circulatory disease mortality (13), neuropsychiatric symptoms (14, 15), reduced bone mineral density, and fractures (16, 17).”
BackgroundSubclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., & Bauer, D. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2460 · Cited by 503 · cited 1×
“Subclinical hyperthyroidism may also be associated with adverse cardiac end points (10, 11) including atrial fibrillation (12), cardiac dysfunction, systemic and circulatory disease mortality (13), neuropsychiatric symptoms (14, 15), reduced bone mineral density, and fractures (16, 17).”
BackgroundFaber, J., & Galløe, A. M. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300350 · Cited by 377
Cited by
The epidemiology of thyroid disease
Vanderpump, M. P. J. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr030 · Cited by 1,179
Razvi, S., Shakoor, A., Vanderpump, M., Weaver, J. U., & Pearce, S. H. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0167 · Cited by 330
“socioeconomic status (12) whereas in another it was its relation with carotid intima-media thickness (27).”
BackgroundInfluentialFranklyn, J. A., & Boelaert, K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60782-4 · Cited by 262
Self-citationAssociation Between Serum Free Thyroxine Concentration and Atrial Fibrillation
Gammage, M. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.928 · Cited by 225
Self-citationParle, J., Roberts, L., Wilson, S., Pattison, H., Roalfe, A., Haque, M. S., Heath, C., Sheppard, M., Franklyn, J., & Hobbs, F. D. R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2571 · Cited by 203
Self-citationLeese, G. P., Flynn, R. V., Jung, R. T., MacDonald, T. M., Murphy, M. J., & Morris, A. D. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03051.x · Cited by 165
Hypothyroidism in the elderly: diagnosis and management
Bensenor, I., Lotufo, P., & Diaz-Olmos (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s23966 · Cited by 139
Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0854 · Cited by 118
Changes in the prevalence of hypothyroidism: the HUNT Study in Norway
Åsvold, B. O., Vatten, L. J., & Bjøro, T. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0459 · Cited by 118
Hypothyroidism in the older population
Leng, O., & Razvi, S. (2019) · Thyroid Research · doi:10.1186/s13044-019-0063-3 · Cited by 112
“Birmingham [17] England 5960 Both sexes ≥ 65 TSH & FT4 0.”
BackgroundParker, L., Moran, G. M., Roberts, L. M., Calvert, M., & McCahon, D. (2014) · Family Practice · doi:10.1093/fampra/cmu035 · Cited by 91
Self-citationFitzgerald, S. P., Bean, N. G., Falhammar, H., & Tuke, J. (2020) · Thyroid® · doi:10.1089/thy.2019.0535 · Cited by 86
Thyroid dysfunction in the elderly
Boelaert, K. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.30 · Cited by 84
Boelaert, K., Maisonneuve, P., Torlinska, B., & Franklyn, J. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3459 · Cited by 82
Self-citationOvert and Subclinical Hypothyroidism in the Elderly: When to Treat
Calsolaro, V., Niccolai, F., Pasqualetti, G., Calabrese, A. M., Polini, A., Okoye, C., Magno, S., Caraccio, N., & Monzani, F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00177 · Cited by 68
McMillan, M., Rotenberg, K. S., Vora, K., Sterman, A. B., Thevathasan, L., Ryan, M. F., Mehra, M., & Sandulli, W. (2016) · Drugs in R&D · doi:10.1007/s40268-015-0116-6 · Cited by 64
Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism
Das, G., Ojewuyi, T. A., Baglioni, P., Geen, J., Premawardhana, L. D., & Okosieme, O. E. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04345.x · Cited by 61
An Analysis of the Natural Course of Subclinical Hyperthyroidism
Díez, J. J., & Iglesias, P. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318187e16d · Cited by 45
The relationship between serum TSH and free T4 in older people: Figure 1
Clark, P. M., Holder, R. L., Haque, S. M., Hobbs, F. D. R., Roberts, L. M., & Franklyn, J. A. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200433 · Cited by 40
Self-citationStability of thyroid function in older adults: the Birmingham Elderly Thyroid Study
Roberts, L., McCahon, D., Johnson, O., Haque, M. S., Parle, J., & Hobbs, F. R. (2018) · British Journal of General Practice · doi:10.3399/bjgp18x698861 · Cited by 30
Self-citationden Elzen, W. P., Lefèbre-van de Fliert, A. A., Virgini, V., Mooijaart, S. P., Frey, P., Kearney, P. M., Kerse, N., Mallen, C. D., McCarthy, V. J., Muth, C., et al. (2015) · British Journal of General Practice · doi:10.3399/bjgp15x683569 · Cited by 18
Republished: The relationship between serum TSH and free T4 in older people
Clark, P. M., Holder, R. L., Haque, S. M., Hobbs, F. D. R., Roberts, L. M., & Franklyn, J. A. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-200433rep · Cited by 13
Self-citationSubclinical thyroid dysfunction symptoms in older adults: cross-sectional study in UK primary care
McCahon, D., Haque, M. S., Parle, J., Hobbs, F. R., & Roberts, L. M. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x708065 · Cited by 8
Self-citation
Metadata
- Authors
- Wilson, S., Parle, J. V., Roberts, L. M., Roalfe, A. K., Hobbs, F. D. R., Clark, P., Sheppard, M. C., Gammage, M. D., Pattison, H. M., Franklyn, J. A., & on behalf of the Birmingham Elderly Thyroid Study Team
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-12-01
- Volume
- 91
- Issue
- 12
- Pages
- 4809-4816
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2102435112
- Cited by
- 129
- References
- 15
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.